Aroa Biosurgery Limited
AROAF
$0.40
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 47.21% | 48.89% | -112.05% | -117.86% | -491.60% |
| Total Depreciation and Amortization | -- | -- | 10.30% | 13.32% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -59.97% | -54.91% | -21.03% | -18.86% | 87.77% |
| Change in Net Operating Assets | -- | -- | 34.15% | 32.34% | -- |
| Cash from Operations | 32.61% | 34.75% | -108.86% | -109.11% | -56.90% |
| Capital Expenditure | 25.09% | 27.47% | 63.94% | 62.95% | 6.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 134.02% | 126.57% | 504.45% | 520.98% | -66.00% |
| Cash from Investing | 307.44% | 294.46% | 453.51% | 463.20% | -79.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -27.79% | -27.79% | -8.90% | -8.90% | -20.69% |
| Issuance of Common Stock | -72.41% | -72.41% | -- | -- | -71.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.99% | -6.99% | -215.79% | -215.79% | -25.14% |
| Cash from Financing | -31.03% | -26.88% | -128.04% | -134.42% | -82.63% |
| Foreign Exchange rate Adjustments | -142.55% | -141.22% | 88.63% | 88.32% | -72.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.60% | 136.40% | 400.95% | 409.23% | -194.56% |
